1394 related articles for article (PubMed ID: 21812415)
1. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
2. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
Al-Jamal WT; Kostarelos K
Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
[TBL] [Abstract][Full Text] [Related]
3. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
4. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties.
Tian B; Al-Jamal WT; Al-Jamal KT; Kostarelos K
Int J Pharm; 2011 Sep; 416(2):443-7. PubMed ID: 21315141
[TBL] [Abstract][Full Text] [Related]
8. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
Al-Jamal WT; Al-Jamal KT; Bomans PH; Frederik PM; Kostarelos K
Small; 2008 Sep; 4(9):1406-15. PubMed ID: 18711753
[TBL] [Abstract][Full Text] [Related]
9. Theranostic magnetic nanoparticles.
Yoo D; Lee JH; Shin TH; Cheon J
Acc Chem Res; 2011 Oct; 44(10):863-74. PubMed ID: 21823593
[TBL] [Abstract][Full Text] [Related]
10. Targeting nanoparticles to cancer.
Wang M; Thanou M
Pharmacol Res; 2010 Aug; 62(2):90-9. PubMed ID: 20380880
[TBL] [Abstract][Full Text] [Related]
11. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
12. Theranostic applications of nanoparticles in cancer.
Ahmed N; Fessi H; Elaissari A
Drug Discov Today; 2012 Sep; 17(17-18):928-34. PubMed ID: 22484464
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications.
Gao J; Gu H; Xu B
Acc Chem Res; 2009 Aug; 42(8):1097-107. PubMed ID: 19476332
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
15. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
16. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N
Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216
[TBL] [Abstract][Full Text] [Related]
17. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticles for multimodal imaging and theragnosis.
Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
[TBL] [Abstract][Full Text] [Related]
19. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
20. Engineering thermosensitive liposome-nanoparticle hybrids loaded with doxorubicin for heat-triggered drug release.
Al-Ahmady Z; Lozano N; Mei KC; Al-Jamal WT; Kostarelos K
Int J Pharm; 2016 Nov; 514(1):133-141. PubMed ID: 27863656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
